Zespół posturalnej tachykardii ortostatycznej (pots) – Rokowania, prognozy i postęp choroby

Zespół posturalnej tachykardii ortostatycznej (pots)
Rokowania, prognozy i postęp choroby

Zespół posturalnej tachykardii ortostatycznej (PoTS) jest przewlekłym schorzeniem o wieloukładowym charakterze, które prowadzi do znacznej niepełnosprawności, jednak prognoza jest stosunkowo korzystna. Badania prospektywne wykazały, że 37% pacjentów po roku od rozpoznania nie spełnia już kryteriów diagnostycznych PoTS, mimo że przyrost częstości akcji serca podczas testu pionizacyjnego pozostaje na poziomie 33,8±15,1 uderzeń/min (w porównaniu do 37,8±14,6 uderzeń/min przy rozpoznaniu). Retrospektywne dane wskazują, że około 80% pacjentów doświadcza poprawy objawów w ciągu 5 lat, a 60% ma minimalne objawy resztkowe. PoTS nie wpływa na skrócenie oczekiwanej długości życia, co jest istotną informacją dla pacjentów i lekarzy prowadzących.

Prognoza w zespole posturalnej tachykardii ortostatycznej (PoTS)

Ogólna prognoza dla pacjentów z PoTS
Długoterminowe obserwacje pacjentów z PoTS
Różnice w rokowaniu w zależności od płci i chorób współistniejących
Skuteczność terapii a rokowanie

Wnioski praktyczne dla klinicystów

Kolejne rozdziały

Prognoza w zespole posturalnej tachykardii ortostatycznej (PoTS)

Zespół posturalnej tachykardii ortostatycznej (PoTS) jest przewlekłym zaburzeniem prowadzącym do znacznej niepełnosprawności z szeregiem problemów wieloukładowych. Prognoza dla pacjentów z tym schorzeniem jest przedmiotem badań i analiz długoterminowych, które dostarczają cennych informacji na temat naturalnego przebiegu choroby oraz skuteczności różnych metod terapeutycznych.¹²

Ogólna prognoza dla pacjentów z PoTS

Zgodnie z dostępnymi danymi, ogólna prognoza dla pacjentów z PoTS jest stosunkowo korzystna. Badania prospektywne wykazały, że większość pacjentów doświadcza poprawy objawów ortostatycznych w ciągu roku od rozpoznania. Co istotne, ponad jedna trzecia pacjentów (37%) po roku obserwacji nie spełnia już kryteriów diagnostycznych PoTS w badaniu pionizacyjnym, chociaż przyrost częstości akcji serca podczas tego testu nie różnił się istotnie statystycznie w porównaniu z wartościami wyjściowymi (33,8±15,1 uderzeń/min po roku vs 37,8±14,6 uderzeń/min przy rozpoznaniu).³

Badania retrospektywne wskazują, że około 80% pacjentów doświadcza poprawy w ciągu około 5 lat, a 60% ma minimalne objawy resztkowe. Te dane są zgodne z obserwacjami, że większość pacjentów z PoTS wykazuje poprawę pod względem objawów, co potwierdza stosunkowo korzystne rokowanie.⁴

Warto podkreślić, że pacjenci z PoTS mają normalną oczekiwaną długość życia – schorzenie to nie wpływa na skrócenie przewidywanego czasu przeżycia.⁵

Długoterminowe obserwacje pacjentów z PoTS

Badanie LTPOTS (Long-Term POTS Outcomes Survey), które objęło 225 pacjentów ze średnim czasem trwania objawów 9,6 lat, jest jednym z największych i najdłuższych badań oceniających wyniki leczenia pacjentów z PoTS. Wyniki tego badania wskazują, że pomimo różnych podejść terapeutycznych, zdecydowana większość pacjentów nie jest całkowicie wolna od objawów PoTS nawet ponad dekadę po postawieniu klinicznej diagnozy.⁶

Istotną obserwacją jest fakt, że schorzenie to rzadko ustępuje spontanicznie, chociaż objawy mogą być modyfikowalne poprzez leczenie. Pacjenci z PoTS często nadal odczuwają objawy pomimo stosowania skutecznych terapii niefarmakologicznych i farmakologicznych.⁷

Różnice w rokowaniu w zależności od płci i chorób współistniejących

Badania wskazują na istotne różnice w przebiegu choroby i rokowaniu w zależności od płci pacjentów. Kobiety z PoTS doświadczają większego obciążenia objawami, większego nasilenia objawów oraz dłuższego czasu trwania objawów w porównaniu z mężczyznami cierpiącymi na to samo schorzenie.⁸

U pacjentów z PoTS często występuje szeroka gama współistniejących zaburzeń, co może wpływać na ogólne rokowanie i skuteczność leczenia. Dokładne zrozumienie obrazu objawów PoTS i cech historycznych może przyczynić się do edukacji lekarzy, poprawy wyników diagnostycznych i pomocy pacjentom w samodzielnym działaniu na rzecz własnego zdrowia.⁹

Skuteczność terapii a rokowanie

Choć PoTS może znacząco zakłócać codzienne życie, różne leki są skuteczne w redukcji objawów tego zespołu. Objawy PoTS mogą pojawiać się i ustępować przez lata, a w około 80% przypadków stan pacjenta ulega poprawie, choć wiele osób wciąż doświadcza objawów resztkowych.¹⁰¹¹

Warto zauważyć, że około jedna trzecia pacjentów zgłasza pojawienie się objawów po przebytej infekcji wirusowej, co może sugerować różne mechanizmy patofizjologiczne i potencjalnie wpływać na rokowanie w różnych podgrupach pacjentów.¹²

Wnioski praktyczne dla klinicystów

W świetle dostępnych danych, lekarze mogą przekazać pacjentom z nowo rozpoznanym PoTS umiarkowanie optymistyczne rokowanie. Chociaż większość pacjentów doświadcza poprawy objawów w ciągu kilku lat, całkowite ustąpienie choroby jest rzadkie. Pacjenci powinni być informowani, że:

PoTS nie skraca oczekiwanej długości życia¹³
Większość pacjentów (około 80%) doświadcza poprawy objawów w ciągu 5 lat¹⁴
Objawy resztkowe mogą utrzymywać się długoterminowo, nawet przy zastosowaniu właściwego leczenia¹⁵
Kobiety mogą doświadczać bardziej nasilonych i długotrwałych objawów niż mężczyźni¹⁶

Kluczowe znaczenie ma indywidualizacja podejścia terapeutycznego oraz regularna ocena skuteczności stosowanych metod leczenia, biorąc pod uwagę przewlekły charakter schorzenia i możliwość utrzymywania się objawów pomimo interwencji terapeutycznych.¹⁷¹⁸

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

Materiały źródłowe

#1 LongâTerm POTS Outcomes Survey: Diagnosis, Therapy, and Clinical Outcomes
https://pmc.ncbi.nlm.nih.gov/articles/PMC11292765/
POTS is a chronic disorder leading to significant disability with a range of multisystem problems. […] Although symptoms can be modifiable, it rarely spontaneously resolves. […] Patients with postural orthostatic tachycardia syndrome continue to be symptomatic, despite effective nonpharmacologic and pharmacologic therapies. […] Female patients with POTS had a greater symptom burden, greater symptom severity, and longer symptom duration than male patients with POTS. […] Various medications are effective in the reduction of POTS symptoms. […] Our LTPOTS survey, with 225 patients and a mean duration of 9.6 years since symptom onset, is one of the largest and longest studies evaluating outcomes in patients with POTS. […] Despite various therapeutic approaches that have been developed for patients, the large majority of patients are not completely free of their POTS symptoms more than a decade following their clinical diagnosis.
#2 POTS: Causes, Symptoms, Diagnosis & Treatment
https://my.clevelandclinic.org/health/diseases/16560-postural-orthostatic-tachycardia-syndrome-pots
The prognosis (outlook) for POTS is generally good, although it can severely disrupt daily living. POTS symptoms may come and go for years. In approximately 80% of cases, the condition improves, but many people have residual symptoms. […] People with POTS have a normal life expectancy. The condition doesn’t decrease life expectancy.
#3 A Prospective, 1-Year Follow-up Study of Postural Tachycardia Syndrome
https://pmc.ncbi.nlm.nih.gov/articles/PMC3538485/
Patients were predominantly young females (n=49, 84%), with 20 patients (34%) reporting an antecedent viral infection before onset of symptoms. […] More than one-third (37%) no longer fulfilled tilt criteria for POTS on follow-up, although heart rate increment on head-up tilt did not differ significantly at 1 year (33.8Â±15.1 beats/min) compared with baseline (37.8Â±14.6 beats/min) for the entire cohort. […] Orthostatic symptoms improved in most patients. […] Our data are in keeping with a relatively favorable prognosis in most patients with POTS. […] The prognosis of patients with POTS is favorable on the basis of prior retrospective studies, which found that 80% of patients improved and 60% had minimal residual symptoms during approximately 5 years. […] Our study indicates that patients generally improve from a symptomatic standpoint, similar to the results of prior retrospective studies on POTS. Overall, the prognosis in POTS continues to be favorable.
#4 A Prospective, 1-Year Follow-up Study of Postural Tachycardia Syndrome
https://pmc.ncbi.nlm.nih.gov/articles/PMC3538485/
Patients were predominantly young females (n=49, 84%), with 20 patients (34%) reporting an antecedent viral infection before onset of symptoms. […] More than one-third (37%) no longer fulfilled tilt criteria for POTS on follow-up, although heart rate increment on head-up tilt did not differ significantly at 1 year (33.8Â±15.1 beats/min) compared with baseline (37.8Â±14.6 beats/min) for the entire cohort. […] Orthostatic symptoms improved in most patients. […] Our data are in keeping with a relatively favorable prognosis in most patients with POTS. […] The prognosis of patients with POTS is favorable on the basis of prior retrospective studies, which found that 80% of patients improved and 60% had minimal residual symptoms during approximately 5 years. […] Our study indicates that patients generally improve from a symptomatic standpoint, similar to the results of prior retrospective studies on POTS. Overall, the prognosis in POTS continues to be favorable.
#5 POTS: Causes, Symptoms, Diagnosis & Treatment
https://my.clevelandclinic.org/health/diseases/16560-postural-orthostatic-tachycardia-syndrome-pots
The prognosis (outlook) for POTS is generally good, although it can severely disrupt daily living. POTS symptoms may come and go for years. In approximately 80% of cases, the condition improves, but many people have residual symptoms. […] People with POTS have a normal life expectancy. The condition doesn’t decrease life expectancy.
#6 LongâTerm POTS Outcomes Survey: Diagnosis, Therapy, and Clinical Outcomes
https://pmc.ncbi.nlm.nih.gov/articles/PMC11292765/
POTS is a chronic disorder leading to significant disability with a range of multisystem problems. […] Although symptoms can be modifiable, it rarely spontaneously resolves. […] Patients with postural orthostatic tachycardia syndrome continue to be symptomatic, despite effective nonpharmacologic and pharmacologic therapies. […] Female patients with POTS had a greater symptom burden, greater symptom severity, and longer symptom duration than male patients with POTS. […] Various medications are effective in the reduction of POTS symptoms. […] Our LTPOTS survey, with 225 patients and a mean duration of 9.6 years since symptom onset, is one of the largest and longest studies evaluating outcomes in patients with POTS. […] Despite various therapeutic approaches that have been developed for patients, the large majority of patients are not completely free of their POTS symptoms more than a decade following their clinical diagnosis.
#7 LongâTerm POTS Outcomes Survey: Diagnosis, Therapy, and Clinical Outcomes
https://pmc.ncbi.nlm.nih.gov/articles/PMC11292765/
POTS is a chronic disorder leading to significant disability with a range of multisystem problems. […] Although symptoms can be modifiable, it rarely spontaneously resolves. […] Patients with postural orthostatic tachycardia syndrome continue to be symptomatic, despite effective nonpharmacologic and pharmacologic therapies. […] Female patients with POTS had a greater symptom burden, greater symptom severity, and longer symptom duration than male patients with POTS. […] Various medications are effective in the reduction of POTS symptoms. […] Our LTPOTS survey, with 225 patients and a mean duration of 9.6 years since symptom onset, is one of the largest and longest studies evaluating outcomes in patients with POTS. […] Despite various therapeutic approaches that have been developed for patients, the large majority of patients are not completely free of their POTS symptoms more than a decade following their clinical diagnosis.
#8 LongâTerm POTS Outcomes Survey: Diagnosis, Therapy, and Clinical Outcomes
https://pmc.ncbi.nlm.nih.gov/articles/PMC11292765/
POTS is a chronic disorder leading to significant disability with a range of multisystem problems. […] Although symptoms can be modifiable, it rarely spontaneously resolves. […] Patients with postural orthostatic tachycardia syndrome continue to be symptomatic, despite effective nonpharmacologic and pharmacologic therapies. […] Female patients with POTS had a greater symptom burden, greater symptom severity, and longer symptom duration than male patients with POTS. […] Various medications are effective in the reduction of POTS symptoms. […] Our LTPOTS survey, with 225 patients and a mean duration of 9.6 years since symptom onset, is one of the largest and longest studies evaluating outcomes in patients with POTS. […] Despite various therapeutic approaches that have been developed for patients, the large majority of patients are not completely free of their POTS symptoms more than a decade following their clinical diagnosis.
#9 LongâTerm POTS Outcomes Survey: Diagnosis, Therapy, and Clinical Outcomes
https://pmc.ncbi.nlm.nih.gov/articles/PMC11292765/
The overwhelming majority of patients are not completely free of their POTS symptoms, even after a more than 9-year period since POTS diagnosis. […] A wide variety of comorbid disorders are also seen in this group of patients. […] Improved understanding of POTS symptom presentation and historical features can inform provider education, improve diagnostic outcomes, and help patients self-advocate when their health care providers are failing them.
#10 LongâTerm POTS Outcomes Survey: Diagnosis, Therapy, and Clinical Outcomes
https://pmc.ncbi.nlm.nih.gov/articles/PMC11292765/
POTS is a chronic disorder leading to significant disability with a range of multisystem problems. […] Although symptoms can be modifiable, it rarely spontaneously resolves. […] Patients with postural orthostatic tachycardia syndrome continue to be symptomatic, despite effective nonpharmacologic and pharmacologic therapies. […] Female patients with POTS had a greater symptom burden, greater symptom severity, and longer symptom duration than male patients with POTS. […] Various medications are effective in the reduction of POTS symptoms. […] Our LTPOTS survey, with 225 patients and a mean duration of 9.6 years since symptom onset, is one of the largest and longest studies evaluating outcomes in patients with POTS. […] Despite various therapeutic approaches that have been developed for patients, the large majority of patients are not completely free of their POTS symptoms more than a decade following their clinical diagnosis.
#11 POTS: Causes, Symptoms, Diagnosis & Treatment
https://my.clevelandclinic.org/health/diseases/16560-postural-orthostatic-tachycardia-syndrome-pots
The prognosis (outlook) for POTS is generally good, although it can severely disrupt daily living. POTS symptoms may come and go for years. In approximately 80% of cases, the condition improves, but many people have residual symptoms. […] People with POTS have a normal life expectancy. The condition doesn’t decrease life expectancy.
#12 A Prospective, 1-Year Follow-up Study of Postural Tachycardia Syndrome
https://pmc.ncbi.nlm.nih.gov/articles/PMC3538485/
Patients were predominantly young females (n=49, 84%), with 20 patients (34%) reporting an antecedent viral infection before onset of symptoms. […] More than one-third (37%) no longer fulfilled tilt criteria for POTS on follow-up, although heart rate increment on head-up tilt did not differ significantly at 1 year (33.8Â±15.1 beats/min) compared with baseline (37.8Â±14.6 beats/min) for the entire cohort. […] Orthostatic symptoms improved in most patients. […] Our data are in keeping with a relatively favorable prognosis in most patients with POTS. […] The prognosis of patients with POTS is favorable on the basis of prior retrospective studies, which found that 80% of patients improved and 60% had minimal residual symptoms during approximately 5 years. […] Our study indicates that patients generally improve from a symptomatic standpoint, similar to the results of prior retrospective studies on POTS. Overall, the prognosis in POTS continues to be favorable.
#13 POTS: Causes, Symptoms, Diagnosis & Treatment
https://my.clevelandclinic.org/health/diseases/16560-postural-orthostatic-tachycardia-syndrome-pots
The prognosis (outlook) for POTS is generally good, although it can severely disrupt daily living. POTS symptoms may come and go for years. In approximately 80% of cases, the condition improves, but many people have residual symptoms. […] People with POTS have a normal life expectancy. The condition doesn’t decrease life expectancy.
#14 A Prospective, 1-Year Follow-up Study of Postural Tachycardia Syndrome
https://pmc.ncbi.nlm.nih.gov/articles/PMC3538485/
Patients were predominantly young females (n=49, 84%), with 20 patients (34%) reporting an antecedent viral infection before onset of symptoms. […] More than one-third (37%) no longer fulfilled tilt criteria for POTS on follow-up, although heart rate increment on head-up tilt did not differ significantly at 1 year (33.8Â±15.1 beats/min) compared with baseline (37.8Â±14.6 beats/min) for the entire cohort. […] Orthostatic symptoms improved in most patients. […] Our data are in keeping with a relatively favorable prognosis in most patients with POTS. […] The prognosis of patients with POTS is favorable on the basis of prior retrospective studies, which found that 80% of patients improved and 60% had minimal residual symptoms during approximately 5 years. […] Our study indicates that patients generally improve from a symptomatic standpoint, similar to the results of prior retrospective studies on POTS. Overall, the prognosis in POTS continues to be favorable.
#15 LongâTerm POTS Outcomes Survey: Diagnosis, Therapy, and Clinical Outcomes
https://pmc.ncbi.nlm.nih.gov/articles/PMC11292765/
POTS is a chronic disorder leading to significant disability with a range of multisystem problems. […] Although symptoms can be modifiable, it rarely spontaneously resolves. […] Patients with postural orthostatic tachycardia syndrome continue to be symptomatic, despite effective nonpharmacologic and pharmacologic therapies. […] Female patients with POTS had a greater symptom burden, greater symptom severity, and longer symptom duration than male patients with POTS. […] Various medications are effective in the reduction of POTS symptoms. […] Our LTPOTS survey, with 225 patients and a mean duration of 9.6 years since symptom onset, is one of the largest and longest studies evaluating outcomes in patients with POTS. […] Despite various therapeutic approaches that have been developed for patients, the large majority of patients are not completely free of their POTS symptoms more than a decade following their clinical diagnosis.
#16 LongâTerm POTS Outcomes Survey: Diagnosis, Therapy, and Clinical Outcomes
https://pmc.ncbi.nlm.nih.gov/articles/PMC11292765/
POTS is a chronic disorder leading to significant disability with a range of multisystem problems. […] Although symptoms can be modifiable, it rarely spontaneously resolves. […] Patients with postural orthostatic tachycardia syndrome continue to be symptomatic, despite effective nonpharmacologic and pharmacologic therapies. […] Female patients with POTS had a greater symptom burden, greater symptom severity, and longer symptom duration than male patients with POTS. […] Various medications are effective in the reduction of POTS symptoms. […] Our LTPOTS survey, with 225 patients and a mean duration of 9.6 years since symptom onset, is one of the largest and longest studies evaluating outcomes in patients with POTS. […] Despite various therapeutic approaches that have been developed for patients, the large majority of patients are not completely free of their POTS symptoms more than a decade following their clinical diagnosis.
#17 LongâTerm POTS Outcomes Survey: Diagnosis, Therapy, and Clinical Outcomes
https://pmc.ncbi.nlm.nih.gov/articles/PMC11292765/
POTS is a chronic disorder leading to significant disability with a range of multisystem problems. […] Although symptoms can be modifiable, it rarely spontaneously resolves. […] Patients with postural orthostatic tachycardia syndrome continue to be symptomatic, despite effective nonpharmacologic and pharmacologic therapies. […] Female patients with POTS had a greater symptom burden, greater symptom severity, and longer symptom duration than male patients with POTS. […] Various medications are effective in the reduction of POTS symptoms. […] Our LTPOTS survey, with 225 patients and a mean duration of 9.6 years since symptom onset, is one of the largest and longest studies evaluating outcomes in patients with POTS. […] Despite various therapeutic approaches that have been developed for patients, the large majority of patients are not completely free of their POTS symptoms more than a decade following their clinical diagnosis.
#18 LongâTerm POTS Outcomes Survey: Diagnosis, Therapy, and Clinical Outcomes
https://pmc.ncbi.nlm.nih.gov/articles/PMC11292765/
The overwhelming majority of patients are not completely free of their POTS symptoms, even after a more than 9-year period since POTS diagnosis. […] A wide variety of comorbid disorders are also seen in this group of patients. […] Improved understanding of POTS symptom presentation and historical features can inform provider education, improve diagnostic outcomes, and help patients self-advocate when their health care providers are failing them.